Search research articles
Contact Us
Filters
Showing results (21-30 of 672) with videos related to
Page
of 68
Sort By:
The Journal of Rheumatology
|
October 11, 2007
Can we combine patient's and doctor's perspective when assessing rheumatoid arthritis disease activity?
Maxime Dougados
Current Opinion in Rheumatology
|
March 31, 2016
Comorbidities in rheumatoid arthritis
Maxime Dougados
Nature Reviews. Rheumatology
|
October 30, 2009
Osteoarthritis: more evidence for non-pharmacological OA therapy
Maxime Dougados
The Journal of Rheumatology. Supplement
|
May 11, 2004
Outcome measures for clinical trials of disease modifying osteoarthritis drugs in patients with hip osteoarthritis
Maxime Dougados
Arthritis and Rheumatism
|
May 18, 2004
Structural progression is also driven by clinical symptoms in patients with osteoarthritis
Maxime Dougados
Current Rheumatology Reports
|
March 12, 2005
How can one develop disease-modifying drugs in osteoarthritis?
Maxime Dougados
Arthritis Research & Therapy
|
October 3, 2008
Lipooxygenase inhibition in osteoarthritis: a potential symptomatic and disease modifying effect?
Maxime Dougados
Journal of Autoimmunity
|
January 14, 2020
Treat to target in axial spondyloarthritis: From its concept to its implementation
Maxime Dougados
Joint Bone Spine
|
June 11, 2013
Do we need therapeutic trials comparing biotherapies to guide treatment selection in patients with rheumatoid arthritis?
Maxime Dougados
Best Practice & Research. Clinical Rheumatology
|
February 18, 2006
Do intra-articular therapies work and who will benefit most?
Laure Gossec, Maxime Dougados
Page
of 68
Search research articles
Search
Showing results (21-30 of 672) with videos related to
Sort By:
Page
of 68
The Journal of Rheumatology
|
October 11, 2007
Can we combine patient's and doctor's perspective when assessing rheumatoid arthritis disease activity?
Maxime Dougados
Current Opinion in Rheumatology
|
March 31, 2016
Comorbidities in rheumatoid arthritis
Maxime Dougados
Nature Reviews. Rheumatology
|
October 30, 2009
Osteoarthritis: more evidence for non-pharmacological OA therapy
Maxime Dougados
The Journal of Rheumatology. Supplement
|
May 11, 2004
Outcome measures for clinical trials of disease modifying osteoarthritis drugs in patients with hip osteoarthritis
Maxime Dougados
Arthritis and Rheumatism
|
May 18, 2004
Structural progression is also driven by clinical symptoms in patients with osteoarthritis
Maxime Dougados
Current Rheumatology Reports
|
March 12, 2005
How can one develop disease-modifying drugs in osteoarthritis?
Maxime Dougados
Arthritis Research & Therapy
|
October 3, 2008
Lipooxygenase inhibition in osteoarthritis: a potential symptomatic and disease modifying effect?
Maxime Dougados
Journal of Autoimmunity
|
January 14, 2020
Treat to target in axial spondyloarthritis: From its concept to its implementation
Maxime Dougados
Joint Bone Spine
|
June 11, 2013
Do we need therapeutic trials comparing biotherapies to guide treatment selection in patients with rheumatoid arthritis?
Maxime Dougados
Best Practice & Research. Clinical Rheumatology
|
February 18, 2006
Do intra-articular therapies work and who will benefit most?
Laure Gossec, Maxime Dougados
Page
of 68